title: Bacterial biosynthesis and maturation of the didemnin anti-cancer agents.
abstract: The anti-neoplastic agent didemnin B from the Caribbean tunicate Trididemnum solidum was the first marine drug to be clinically tested in humans. Because of its limited supply and its complex cyclic depsipeptide structure, considerable challenges were encountered during didemnin B's development that continue to limit aplidine (dehydrodidemnin B), which is currently being evaluated in numerous clinical trials. Herein we show that the didemnins are bacterial products produced by the marine α-proteobacteria Tistrella mobilis and Tistrella bauzanensis via a unique post-assembly line maturation process. Complete genome sequence analysis of the 6,513,401 bp T. mobilis strain KA081020-065 with its five circular replicons revealed the putative didemnin biosynthetic gene cluster (did) on the 1,126,962 bp megaplasmid pTM3. The did locus encodes a 13-module hybrid non-ribosomal peptide synthetase-polyketide synthase enzyme complex organized in a collinear arrangement for the synthesis of the fatty acylglutamine ester derivatives didemnins X and Y rather than didemnin B as first anticipated. Imaging mass spectrometry of T. mobilis bacterial colonies captured the time-dependent extracellular conversion of the didemnin X and Y precursors to didemnin B, in support of an unusual post-synthetase activation mechanism. Significantly, the discovery of the didemnin biosynthetic gene cluster may provide a long-term solution to the supply problem that presently hinders this group of marine natural products and pave the way for the genetic engineering of new didemnin congeners.
authors.affiliation: KAUST Global Collaborative Research, Division of Life Science, School of Science, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
authors.forename: Ying
authors.initials: Y
authors.lastname: Xu
authors.forename: Roland D
authors.initials: RD
authors.lastname: Kersten
authors.forename: Sang-Jip
authors.initials: SJ
authors.lastname: Nam
authors.forename: Liang
authors.initials: L
authors.lastname: Lu
authors.forename: Abdulaziz M
authors.initials: AM
authors.lastname: Al-Suwailem
authors.forename: Huajun
authors.initials: H
authors.lastname: Zheng
authors.forename: William
authors.initials: W
authors.lastname: Fenical
authors.forename: Pieter C
authors.initials: PC
authors.lastname: Dorrestein
authors.forename: Bradley S
authors.initials: BS
authors.lastname: Moore
authors.forename: Pei-Yuan
authors.initials: PY
authors.lastname: Qian
mesh_terms: D000970:Antineoplastic Agents / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism*; D001688:Biological Products / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism*; D047630:Depsipeptides / Q000737:chemistry / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism*; D005798:Genes, Bacterial; D013058:Mass Spectrometry; D005810:Multigene Family; D020560:Proteobacteria / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D001688:Biological Products; D047630:Depsipeptides; C030051:didemnins